Based on the comparison of the ALMS+BBS group with the obesity and control groups, changes were observed in the levels of 33, 19 and 34 metabolites in saliva, GCF, and serum samples, respectively ( Table 2, Table S4, Table S5). Here, BBS2 is linked to obesity disorder.